MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
NCT02845635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2200
Last updated 2022-04-20
Summary
The purpose of this study is to better characterize the fluctuations in multiple sclerosis symptoms and their relationship to medications, to length/extent of disease, and to a variety of physiologic measures.
Conditions
Interventions
- OTHER
-
Personal history of multiple sclerosis
Participants will be stratified into one of four cohorts based on their experience (or lack of experience) with the three major forms of multiple sclerosis.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Fletcher L Hartsell, MD MPH · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-29
- Primary Completion
- 2021-07-28
- Completion
- 2021-07-28
Countries
- United States
Study Locations
More Related Trials
-
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
NCT01723709 ·Status: COMPLETED
-
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
NCT04892134 ·Status: RECRUITING
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611 ·Status: TERMINATED ·Phase: PHASE3
-
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
NCT01737372 ·Status: COMPLETED
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
NCT00919217 ·Status: TERMINATED
-
The MS-LINK™ Outcomes Study
NCT04735406 ·Status: COMPLETED
-
A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years
NCT01084798 ·Status: COMPLETED
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients
NCT05503524 ·Status: NOT_YET_RECRUITING
-
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
NCT02301247 ·Status: COMPLETED ·Phase: NA
-
The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis
NCT06290453 ·Status: NOT_YET_RECRUITING
-
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
NCT01776060 ·Status: COMPLETED
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 ·Status: WITHDRAWN
-
Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells
NCT01587690 ·Status: COMPLETED
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Incidence, and Survival Medical Expenditure of Patients With Multiple Sclerosis
NCT04022564 ·Status: UNKNOWN
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Mesenchymal Stem Cells for Multiple Sclerosis
NCT01730547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Coagulation in Multiple Sclerosis
NCT01711255 ·Status: COMPLETED
-
Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis
NCT04834401 ·Status: COMPLETED
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING